B.well Connected Health and myTomorrows Team Up to Improve Clinical Trial Access for Patients

Revolutionizing Clinical Trial Accessibility

In a groundbreaking partnership, b.well Connected Health and myTomorrows have united forces to enhance access to clinical trials for patients navigating complex healthcare pathways. By integrating b.well’s robust healthcare technology with myTomorrows’ proven clinical trial matching platform, this collaboration seeks to significantly reduce the burden on patients while advancing the efficiency of enrollment processes for clinical trials.

The Vision Behind the Partnership

The primary objective of this alliance is to create a seamless connection between patients seeking clinical trial participation and the vital data that determines their eligibility. With b.well’s innovative FHIR-based platform, which consolidates health information from an impressive network of 2.4 million providers and over 350 health monitoring devices, patients will now have their health data unified in a way that paves the path for easier trial accessibility.

Kristen Valdes, the Founder and CEO of b.well, emphasized that the current healthcare system often complicates access to clinical trials. She stated, "A patient and their family will go to great lengths to partake in a clinical trial that could alter their life. However, the existing structure does not support that effectively. Through our collaboration, we empower patients to share their health data, enabling them to find trials that may offer hope."

How It Works

The synergy between b.well and myTomorrows brings forth a dynamic solution: automated eligibility matching driven by artificial intelligence. This cutting-edge technology not only minimizes repetitive data collection but also helps patients and healthcare teams view all potential clinical trial opportunities in one place. The result is a more efficient pathway for patients seeking innovative treatments. Additionally, for pharmaceutical companies and trial sites, this integration encourages the recruitment of a more diverse patient population, addressing a significant challenge in clinical research today.

Michel van Harten, MD, CEO at myTomorrows, noted that by combining their matching expertise with b.well’s health data capabilities, they can reach a wider array of patients across various communities, effectively eliminating the barriers that previously hindered access to novel medications. He expressed optimism about the future, stating, "This partnership opens a new chapter in clinical trial recruitment, breaking down traditional hurdles and enhancing patient access to emerging treatments."

The Impact of Unified Health Data

A central element of this initiative is the commitment from both organizations to innovate at the intersection of health data unification and clinical trial matching technology. By streamlining processes and improving transparency, they aspire to accelerate patient access to groundbreaking therapies while benefiting the pharmaceutical industry's development timelines. This approach not only enhances patient experiences but also aligns with a larger trend toward accountability and efficiency in healthcare.

The collaboration reflects a significant shift within the healthcare landscape, where real-time utilization of health data becomes fundamental in expediting insights and decision-making processes. It promises advancements that can catalyze a transformation in how clinical trials are conducted and managed.

Conclusion

The partnership between b.well Connected Health and myTomorrows represents a pivotal movement in bridging the gap between patients and clinical trial opportunities. With unified health data and intelligent matching capabilities, the results of this alliance are anticipated to significantly enhance the clinical trial experience, making it more patient-centric and accessible. This forward-thinking initiative reflects the ongoing evolution in healthcare technology—one that prioritizes patient needs and empowers individuals at critical moments in their health journeys.